Multiple surveys that were conducted to examine the sentiments concerning coronavirus disease 19 (Covid-19) vaccination have exposed new levels of volatility around vaccine hesitancy, particularly when the hesitancy is powered by digital media platforms.
We sought to report comprehensive trends in injury-related mortality and morbidity for adolescents aged 10–24 years during the past three decades.
Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties.
We measured life expectancy at birth, by sex and year, for subgroups of people reporting Hispanic, non-Hispanic Black, or non-Hispanic White race/ethnicity.
We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
This analysis estimated life expectancy for five racial–ethnic groups, in 3,110 US counties over 20 years, to describe spatial–temporal variations in life expectancy and disparities between racial–ethnic groups.
We identify the pattern of garbage-coded deaths in the world and present the methods used to determine their redistribution to generate more plausible cause of death assignments.
We aimed to use comparable and standardised data sources to estimate human resources for health (HRH) densities globally, and to examine the relationship between a subset of HRH cadres and UHC effective coverage performance.
Our analysis presents the first ever estimates of entire distributions of stunting, wasting, and underweight for each of 204 countries and territories from 1990 to 2020 for children less than 5 years old by age group and sex.
The trends in vaccine confidence and resistance have implications for updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms from intentional and unintentional vaccine scares.
We aimed to estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against household exposure to COVID-19.
In this study, we aimed to provide a novel approach to estimating past SARS-CoV-2 infections, combining data from reported cases, reported deaths, excess deaths attributable to COVID-19, hospitalizations, and seroprevalence surveys
We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades.
In this study, we conducted a cost-effectiveness analysis of a Vitamin A Supplementation scale-up in Nigeria, Kenya, and Burkina Faso.
In this systematic analysis, we present the national and subnational estimates of the burden of disease in Iran using the Global Burden of Disease Study 2019.
We aimed to examine injury-related morbidity and mortality among adults aged 50 years or older in 22 Eastern Mediterranean countries.
We estimated the burden of mental disorders, substance use disorders, and self-harm in people aged 10-24 in 31 European countries.
NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning.
We undertook a comprehensive assessment of the burden of disease in Nigeria and compared outcomes to other west African countries.
The GBD 2019 Ethiopia subnational analysis aimed to measure the progress and disparities in health across nine regions and two chartered cities.
We modelled healthcare spending attributable to dementia from 2000 to 2019 and expected estimated future spending from 2020 to 2050 under multiple scenarios.
Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from the COVID-19 pandemic in 191 countries and territories, and 252 subnational units for selected countries, from Jan 1, 2020, to Dec 31, 2021.
We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) to estimate mortality and disability trends for the population aged ≥70 and evaluate patterns in causes of death, disability, and risk factors.
Gender is emerging as a significant factor in the social, economic, and health effects of COVID-19; yet most existing studies have focused on its direct impact on health. Here we explore the indirect effects of COVID-19 on gender disparities globally.
The infection–fatality ratio (IFR) is a metric that quantifies the likelihood of an individual dying once infected with a pathogen. Understanding the determinants of IFR variation for COVID-19, the disease caused by the SARS-CoV-2 virus, has direct implications for mitigation efforts with respect to clinical practice, non-pharmaceutical interventions, and the prioritisation of risk groups for targeted vaccine delivery.